HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
GKOS
Glaukos Corporation
Healthcare Medical Devices · California, USA · Reports in usd
Market Cap: $6.98B
Market Cap
$6.98B
Enterprise Val
$6.80B
P/E Ratio
-37.17
P/B Ratio
10.63
Trailing PEG (1Y)
-0.13
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$656.2M
Gross Margin-1.06%
Profit Margin-1.06%
Return on Equity-25.41%
Return on Assets-19.52%
Current Ratio4.69
Debt/Equity0.16
LT Debt/Equity0.16
Revenue Per Share2.49

Income Statement

Dec 31, 2025
Revenue$143.1M
Cost of Revenue$144.6M
Gross Profit-$1.5M
R&D$43.7M
SG&A$94.7M
Operating Expenses$138.4M
Operating Income-$139.9M
Interest Expense$1.1M
Tax Expense-$6.2M
Net Income-$133.7M
EPS (Basic)$-2.33
EPS (Diluted)$-2.33
EBIT-$138.7M
EBITDA-$125.4M
Consolidated Income-$133.7M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$94.6M
Accounts Receivable$108.6M
Inventory$63.6M
Current Assets$475.0M
LT Investments$0.00
Property, Plant & Equipment$184.2M
Intangibles$208.6M
Non-Current Assets$418.5M
Total Assets$893.5M
Accounts Payable$24.6M
Current Debt$0.00
Current Liabilities$101.3M
LT Debt$103.9M
Non-Current Liabilities$136.1M
Total Liabilities$237.3M
Total Debt$103.9M
Retained Earnings-$933.1M
Shareholder Equity$656.2M
Shares Outstanding57,434,740

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$6.8M
Investing Cash Flow-$15.9M
Financing Cash Flow$2.4M
CapEx-$2.9M
Free Cash Flow$3.9M
Depreciation & Amort.$13.2M
Stock-Based Comp$17.3M
Acquisitions / Disposals$0.00
Investment Activity-$12.2M
Debt Issued/Repaid-$300.0K
Equity Issued/Repaid$2.9M
Dividends Paid$0.00
Net Change in Cash-$7.4M
Data cached · Meta live · Daily live · Statements live · TTL 24h